Assembly Health Committee advances wide-ranging health bills including prior‑authorization reform, insulin cap and staffing enforcement

SACRAMENTO — The California State Assembly Health Committee on Tuesday, July 15, advanced a series of health‑sector bills, moving multiple measures to the Appropriations Committee after hearings that ranged from technical amendments to emotional personal testimony.

Among the measures the committee cleared were Senate Bill 306 (Becker), a prior‑authorization reform the author said aims to limit unnecessary prior authorization; SB 40 (Wiener), capping monthly insulin co‑payments at $35 for a 30‑day supply; SB 363 (Wiener), requiring more data and penalties tied to independent medical review overturn rates; SB 596 (Menjivar), tightening documentation when hospitals claim an “on‑call” waiver for nurse‑to‑patient ratio fines; SB 35 (Umberg), which would allow local agencies to inspect suspected unlicensed sober‑living homes when state investigators do not act within statutory timelines; SB 62 (Menjivar), to codify additions to California’s essential health benefits should the federal government approve changes; SB 535 (Richardson), the Obesity Care Access Act; SB 402 (Valadares), a technical move of autism provider qualifications into the Business and Professions Code; and SB 257 (Wahab), which would bar certain insurer reimbursement liens tied to surrogacy and add pregnancy as a qualifying life event for enrollment. The committee also heard SB 530 (Richardson) on Medi‑Cal network adequacy.

Why it matters: The bills address multiple pressure points in California health policy: administrative burdens on clinicians, drug affordability, mental‑health access, hospital staffing and enforcement, and coverage expansions. Several measures were debated at length and drew diverse stakeholder views — provider associations, hospitals, consumer advocates, insurers and labor unions — reflecting tradeoffs between access, cost and regulatory design.

SB 306 — prior authorization reform: Senator Becker described SB 306 as an attempt to cut “red tape” that delays care, citing a 2023 AMA survey that doctors complete dozens of prior authorizations weekly and said those delays sometimes produce hospitalizations. The version heard includes late technical assistance amendments from the Department of Managed Health Care (DMHC) and the California Department of Insurance (CDI) that shift much of the exemption determination to regulators, who would use utilization data and specified safeguards (including fraud and patient‑safety considerations) to exempt services or drugs from prior authorization. Supporters including the California Medical Association and California Hospital Association said the bill would reduce administrative burden; opponents — health plans and insurers — urged caution about thresholds and drug inclusions and asked for clarity on metrics. The committee moved SB 306 as amended to appropriations.

SB 40 — insulin affordability: Senator Wiener’s Insulin Affordability Act would cap co‑pays for a 30‑day insulin supply at $35 and ban step‑therapy requirements unless plans cover at least one insulin per drug type. Doctors and patient advocates described rationing and financial hardship. Dr. Shagun Bilesh testified: “Insulin is not a luxury. It’s life‑saving.” Students and diabetes advocates urged passage. The committee approved SB 40 as proposed and sent it to appropriations.

SB 363 — IMR data and accountability: Senator Wiener said many denials are overturned on Independent Medical Review (IMR). Sponsors argued that overturn rates — particularly in youth behavioral health, where advocates cited an 82% overturn rate for youth mental‑health denials — indicate systemic problems needing transparency and stronger accountability. The bill would require broader data reporting and create penalties when overturn rates exceed statutory thresholds; insurers warned that penalties could be excessive and that clinical differences of opinion are inherent. The committee advanced SB 363 to appropriations.

SB 596 — nurse staffing and on‑call documentation: Senator Menjivar framed SB 596 as narrowing a “loophole” that hospitals use to avoid fines after being found in violation of statutorily required nurse‑to‑patient ratios. The bill does not change ratios or fines; it tightens documentation and verification hospitals must produce when claiming a waiver because they called an on‑call list. Nurse union witnesses said the bill will help enforcement; hospitals and some health systems said the proposal would reduce operational flexibility and increase costs. Committee members asked about collective‑bargaining implications and enforcement funding; the bill was advanced to appropriations after amendments that removed a 10% numeric on‑call threshold to increase flexibility.

SB 35 — unlicensed sober living homes: Senator Umberg said the bill lets cities and counties conduct on‑site inspections of residential recovery homes when the Department of Health Care Services (DHCS) fails to investigate or complete an investigation within the bill’s timelines; sponsor Carolyn Grinder (League of California Cities) said recent audits show DHCS is understaffed. The bill drew support from local governments and mental‑health advocates and respectful opposition from some county behavioral‑health directors concerned about implementation. The committee moved the measure to appropriations.

SB 62 — essential health benefits: Senator Menjivar presented SB 62 as a placeholder to codify additions to California’s benchmark essential health benefits if and when the federal government approves the state’s request. The bill would add benefits such as hearing aids, certain durable medical equipment and specified infertility services to the state benchmark if federal approval is granted. Supporters stressed long‑term benefits to consumers; one opponent from the California Family Council noted policy objections. The committee advanced the bill to appropriations.

SB 535 — Obesity Care Access Act: Senator Richardson said SB 535 would require coverage for bariatric surgery and at least one FDA‑approved anti‑obesity medication while preserving utilization controls. Medical witnesses said obesity is a chronic disease linked to diabetes, heart disease and cancer and argued coverage can lower downstream costs. Insurers remained concerned about the fiscal impact of broad coverage for newer GLP‑1‑class medicines and the potential premium impact; the bill was advanced to appropriations with committee amendments.

SB 402 — autism provider qualifications: Senator Valadares said the measure moves existing qualification language for qualified autism service professionals into the Business and Professions Code without changing standards, to align provider qualifications with other healing‑arts professions. Sponsors said the change is technical and aims to improve long‑term regulatory clarity; some autism‑services groups and clinicians urged caution that the change not be used to restrict access. The committee approved the bill.

SB 530 (Medi‑Cal network adequacy) and SB 5 30 / SB 5 30 naming: Senator Richardson (as reflected in the hearing) presented amendments and a stakeholder process to preserve and update Medi‑Cal time‑and‑distance standards after lawmakers approved the original statute in 2017. Legal services and consumer advocates described cases in which Medi‑Cal enrollees faced monthslong waits for specialists; SB 530 would extend existing standards, require transparent data publication and a stakeholder process to inform updated standards. The committee advanced the measure, noting the bill’s intent to preserve access and require updated standards informed by data.

SB 257 — surrogacy, liens and pregnancy as a qualifying life event: Senator Wahab said SB 257 would bar insurers from seeking reimbursement or placing liens against surrogates’ compensation for covered pregnancy care in specified circumstances and would add pregnancy as a qualifying life event for enrollment. Intended‑parent and surrogate witnesses described billing and lien practices that resulted in unexpected charges. Insurer witnesses warned that adding pregnancy as a condition‑specific special enrollment period could destabilize individual markets and showed a CHBRP estimate of budgetary impact; supporters argued the measure addresses discrimination and coverage gaps. The committee advanced the bill to appropriations.

Votes at a glance: The committee recorded votes sending these measures to the Appropriations Committee (motions and seconds were made on the floor and the clerk called roll). For each bill the committee moved the measure as follows: SB 306 (due pass as amended to Appropriations); SB 35 (due pass as amended to Appropriations); SB 62 (due pass to Appropriations); SB 40 (due pass as amended to Appropriations); SB 363 (due pass as amended to Appropriations); SB 402 (due pass as amended to Appropriations); SB 530/SB 5 30 (due pass as amended to Appropriations); SB 535 (due pass as amended to Appropriations); SB 257 (due pass as amended to Appropriations); SB 596 (due pass to Appropriations). (Clerk’s roll calls and motions are part of the public hearing record.)

What’s next: Most measures in this hearing were referred to the Appropriations Committee, a common next step for bills with potential fiscal impacts. Several authors and stakeholders said they will continue negotiations this summer on technical fixes and fiscal implementation. The committee’s transcript shows continuing negotiations between authors, the Department of Managed Health Care, insurers and health‑care providers on thresholds, enforcement language, and the scope of drug exclusions.

Quotes: Senator Becker on prior authorization: “Doctors are spending more time on paperwork than with their patients.” Dr. Shagun Bilesh on insulin access: “Insulin is not a luxury. It’s life‑saving.” Liz Helms (California Chronic Care Coalition) on denials and appeals: “The prevailing model seems to be deny first, delay, and maybe the patient will go away.”

The hearing record includes extensive stakeholder testimony and multiple late‑filed technical amendments; committee staff and authors said they expect continued amendment and negotiation before floor action.